Oct 13, 2025
Check out the latest UK Price Watch article in the Generics Bulletin for analysis and insight on September’s product launches, the biggest risers, the biggest fallers and the fastest movers…. with market data provided by WaveData. Dave Wallace editor at Generics...
Sep 24, 2025
At last week’s EMIG Quarterly meeting Donal Markey, Assistant director of Programmes, Transformation and Performance, said that the Irish health service had been reorganised just once while England’s NHS had been reorganised 7 times. As we are in our Silver...
Sep 18, 2025
There seem to be a number of things going on with this product in the long-term. The first thing we can see is that market prices rose dramatically to April 2020 at which point a Concession was announced and an increase in the Drug Tariff introduced fairly shortly...
Sep 16, 2025
Leslie Galloway, EMIG Chairman, shared his analysis of VPAG. Here’s Charles’ key takeaways: · The NHS VPAG rebate is £1bn over 3 years and so is a fixed rebate with risk share. · Global Pharma CEOs have asked for lower rebates and a better deal, that...
Sep 16, 2025
Charles Joynson, WaveData MD, decided to have a look at the differences between the average market price for generics and the English drug tariff. He wanted to know if the gap between the two was being squeezed, resulting in some of the misery pharmacists are going...
Sep 15, 2025
Over the last 10 years Olanzapine tablets have suffered four shortages along with price spikes and concessions. The most severe of these was in 2017 when prices for the 20mg 28 tablet pack went up as high as £115 on something that normally sells for £2. High levels of...
